Rankings
▼
Calendar
OMER Q4 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$835M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
-68.2% YoY
Gross Profit
$11M
99.2% margin
Operating Income
-$34M
-318.1% margin
Net Income
-$37M
-350.6% margin
EPS (Diluted)
$-0.60
QoQ Revenue Growth
-59.3%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$181M
Total Liabilities
$302M
Stockholders' Equity
-$121M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$33M
-68.2%
Gross Profit
$11M
$33M
-68.1%
Operating Income
-$34M
-$24M
-42.6%
Net Income
-$37M
-$29M
-27.5%
← FY 2020
All Quarters
Q1 2021 →